17-40861722-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000223.4(KRT12):​c.1424A>G​(p.Gln475Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00147 in 1,613,904 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00095 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 5 hom. )

Consequence

KRT12
NM_000223.4 missense

Scores

1
9
9

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 5.29

Publications

1 publications found
Variant links:
Genes affected
KRT12 (HGNC:6414): (keratin 12) KRT12 encodes the type I intermediate filament chain keratin 12, expressed in corneal epithelia. Mutations in this gene lead to Meesmann corneal dystrophy. [provided by RefSeq, Jul 2008]
KRT12 Gene-Disease associations (from GenCC):
  • corneal dystrophy, Meesmann, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Meesmann corneal dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0133211315).
BP6
Variant 17-40861722-T-C is Benign according to our data. Variant chr17-40861722-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 2647749.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000952 (145/152354) while in subpopulation NFE AF = 0.00157 (107/68036). AF 95% confidence interval is 0.00133. There are 0 homozygotes in GnomAd4. There are 62 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 145 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRT12NM_000223.4 linkc.1424A>G p.Gln475Arg missense_variant Exon 8 of 8 ENST00000251643.5 NP_000214.1 Q99456
LOC105371777XR_934754.3 linkn.63+10862T>C intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRT12ENST00000251643.5 linkc.1424A>G p.Gln475Arg missense_variant Exon 8 of 8 1 NM_000223.4 ENSP00000251643.4 Q99456
ENSG00000265359ENST00000579136.1 linkn.62-1364T>C intron_variant Intron 1 of 1 3
ENSG00000265359ENST00000818906.1 linkn.61+10862T>C intron_variant Intron 1 of 2

Frequencies

GnomAD3 genomes
AF:
0.000946
AC:
144
AN:
152236
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00157
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00116
AC:
290
AN:
250234
AF XY:
0.00126
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000665
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000508
Gnomad NFE exome
AF:
0.00147
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.00153
AC:
2230
AN:
1461550
Hom.:
5
Cov.:
29
AF XY:
0.00152
AC XY:
1102
AN XY:
727102
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33474
American (AMR)
AF:
0.000648
AC:
29
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00341
AC:
89
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39672
South Asian (SAS)
AF:
0.00191
AC:
165
AN:
86252
European-Finnish (FIN)
AF:
0.000524
AC:
28
AN:
53418
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00165
AC:
1832
AN:
1111736
Other (OTH)
AF:
0.00129
AC:
78
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
99
198
298
397
496
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
72
144
216
288
360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000952
AC:
145
AN:
152354
Hom.:
0
Cov.:
32
AF XY:
0.000832
AC XY:
62
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41574
American (AMR)
AF:
0.000457
AC:
7
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00103
AC:
5
AN:
4832
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00157
AC:
107
AN:
68036
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00108
Hom.:
0
Bravo
AF:
0.000839
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00221
AC:
19
ExAC
AF:
0.00113
AC:
137
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KRT12: BP4 -

Nov 02, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

KRT12-related disorder Benign:1
May 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T;T
Eigen
Benign
0.16
Eigen_PC
Uncertain
0.25
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
.;D
M_CAP
Uncertain
0.10
D
MetaRNN
Benign
0.013
T;T
MetaSVM
Uncertain
0.058
D
MutationAssessor
Uncertain
2.0
M;M
PhyloP100
5.3
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.7
.;N
REVEL
Uncertain
0.33
Sift
Uncertain
0.0010
.;D
Sift4G
Uncertain
0.0070
.;D
Polyphen
0.36
B;B
Vest4
0.20
MVP
0.53
MPC
0.0013
ClinPred
0.061
T
GERP RS
4.6
Varity_R
0.22
gMVP
0.63
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150149178; hg19: chr17-39017974; COSMIC: COSV105091260; API